awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34521260-520F8757-A973-428F-AD7A-15BFD189412F
Q34521260-520F8757-A973-428F-AD7A-15BFD189412F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34521260-520F8757-A973-428F-AD7A-15BFD189412F
A phase I study of the investigational NEDD8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924) in patients with metastatic melanoma.
P2860
Q34521260-520F8757-A973-428F-AD7A-15BFD189412F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34521260-520F8757-A973-428F-AD7A-15BFD189412F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
153e36e59200fe81fd376c9adcf9113ec4a60777
P2860
Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: results of a phase 1/2 study